Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Now, the Federal Trade Commission (FTC) is suing the largest PBMs for allegedly increasing the cost of insulin for patients with diabetes. These middlemen manage the drug benefits for virtually ...

By taking steps to hold middlemen ... Affordable Insulin Now Act moves towards the US Senate. Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin ... three PBMs are the ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

In a study presented at the Summit on Stem Cell Derived Islets in Boston, researchers report on encouraging results using an ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

INSULIN LITIGATION DEEP-DIVE — As Congress ... in a New Jersey district court against the three major pharmacy middlemen — CVS Caremark, Express Scripts and OptumRx — and three insulin ...

According to researchers, the drug holds great promise for the tens of millions of insulin-requiring diabetics worldwide. Low blood glucose, or hypoglycemia, can be dangerous for diabetics.

“Your drug has a generic” that may cost less. In the case of insulin, if the generic is covered, it won’t cost less but chances are the plan will save money. And that can be a factor in what ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...